Molecule Information
General Information of the Molecule (ID: Mol01179)
Type(s) of Resistant Mechanism of This Molecule
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Drug
Approved Drug(s)
3 drug(s) in total
Cisplatin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Lung small cell carcinoma | [1] | |||
Resistant Disease | Lung small cell carcinoma [ICD-11: 2C25.2] | |||
Resistant Drug | Cisplatin | |||
Molecule Alteration | Methylation | Up-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Inhibition | hsa04210 | |
In Vitro Model | NCI-H446 cells | Lung | Homo sapiens (Human) | CVCL_1562 |
NCI-H69 cells | Lung | Homo sapiens (Human) | CVCL_1579 | |
Experiment for Molecule Alteration |
Western blot analysis | |||
Experiment for Drug Resistance |
CCK8 assay; Flow cytometry assay | |||
Mechanism Description | H3kH3k27me3 induces multidrug resistance in small cell lung cancer by affecting HOXA1 DNA methylation via regulation of the LncRNA HOTAIR. |
Doxorubicin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Lung small cell carcinoma | [1] | |||
Resistant Disease | Lung small cell carcinoma [ICD-11: 2C25.2] | |||
Resistant Drug | Doxorubicin | |||
Molecule Alteration | Methylation | Up-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Inhibition | hsa04210 | |
In Vitro Model | NCI-H446 cells | Lung | Homo sapiens (Human) | CVCL_1562 |
NCI-H69 cells | Lung | Homo sapiens (Human) | CVCL_1579 | |
Experiment for Molecule Alteration |
Western blot analysis | |||
Experiment for Drug Resistance |
CCK8 assay; Flow cytometry assay | |||
Mechanism Description | H3kH3k27me3 induces multidrug resistance in small cell lung cancer by affecting HOXA1 DNA methylation via regulation of the LncRNA HOTAIR. |
Etoposide
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Disease Class: Lung small cell carcinoma | [1] | |||
Resistant Disease | Lung small cell carcinoma [ICD-11: 2C25.2] | |||
Resistant Drug | Etoposide | |||
Molecule Alteration | Methylation | Up-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | Cell apoptosis | Inhibition | hsa04210 | |
In Vitro Model | NCI-H446 cells | Lung | Homo sapiens (Human) | CVCL_1562 |
NCI-H69 cells | Lung | Homo sapiens (Human) | CVCL_1579 | |
Experiment for Molecule Alteration |
Western blot analysis | |||
Experiment for Drug Resistance |
CCK8 assay; Flow cytometry assay | |||
Mechanism Description | H3kH3k27me3 induces multidrug resistance in small cell lung cancer by affecting HOXA1 DNA methylation via regulation of the LncRNA HOTAIR. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.